|
Name |
Aspergillussanone F
|
Molecular Formula | C35H46O8 | |
IUPAC Name* |
2,4,6,9-tetrahydroxy-2-[10-[5-(2-hydroxypropan-2-yl)-2-methyloxolan-2-yl]-3,7-dimethyldeca-2,6-dienyl]-5,7-dimethylphenalene-1,3-dione
|
|
SMILES |
CC(=CCC1(O)C(=O)c2c(O)cc(C)c3c(O)c(C)c(O)c(c23)C1=O)CCC=C(C)CCCC1(C)CCC(C(C)(C)O)O1
|
|
InChI |
InChI=1S/C35H46O8/c1-19(12-9-15-34(7)16-14-24(43-34)33(5,6)41)10-8-11-20(2)13-17-35(42)31(39)26-23(36)18-21(3)25-27(26)28(32(35)40)30(38)22(4)29(25)37/h10,13,18,24,36-38,41-42H,8-9,11-12,14-17H2,1-7H3/b19-10+,20-13+/t24-,34-,35-/m0/s1
|
|
InChIKey |
LYRPKHOKWBCQED-KDXFNGLKSA-N
|
|
Synonyms |
NA
|
|
CAS | NA | |
PubChem CID | NA | |
ChEMBL ID | NA |
Chemical Classification: |
|
|
---|
Endophyte ID | Endophyte Name | Family | Genus | Taxonomy ID | GenBank ID | Closest GenBank ID | Reference | |
---|---|---|---|---|---|---|---|---|
Endophyte ID | Endophyte Name | Family | Genus | Taxonomy ID | GenBank ID | Closest GenBank ID | Reference |
Bioactivity Name | Target ID | Target Name | Target Type | Target Organism | Target Organism ID | Potency of Bioactivity | Activity Type | Value | Unit | Endophyte ID | Endophyte Name | |
---|---|---|---|---|---|---|---|---|---|---|---|---|
Bioactivity Name | Target ID | Target Name | Target Type | Target Organism | Target Organism ID | Potency of Bioactivity | Activity Type | Value | Unit | Endophyte ID | Endophyte Name |
Molecular Weight: | 594.75 | ALogp: | 6.6 |
HBD: | 5 | HBA: | 8 |
Rotatable Bonds: | 10 | Lipinski's rule of five: | Rejected |
Polar Surface Area: | 144.5 | Aromatic Rings: | 4 |
Heavy Atoms: | 43 | QED Weighted: | 0.153 |
Caco-2 Permeability: | -4.738 | MDCK Permeability: | 0.00001230 |
Pgp-inhibitor: | 0.733 | Pgp-substrate: | 0.008 |
Human Intestinal Absorption (HIA): | 0.75 | 20% Bioavailability (F20%): | 0.945 |
30% Bioavailability (F30%): | 0.017 |
Blood-Brain-Barrier Penetration (BBB): | 0.021 | Plasma Protein Binding (PPB): | 97.77% |
Volume Distribution (VD): | 1.503 | Fu: | 2.92% |
CYP1A2-inhibitor: | 0.098 | CYP1A2-substrate: | 0.559 |
CYP2C19-inhibitor: | 0.276 | CYP2C19-substrate: | 0.499 |
CYP2C9-inhibitor: | 0.696 | CYP2C9-substrate: | 0.713 |
CYP2D6-inhibitor: | 0.532 | CYP2D6-substrate: | 0.135 |
CYP3A4-inhibitor: | 0.263 | CYP3A4-substrate: | 0.468 |
Clearance (CL): | 1.774 | Half-life (T1/2): | 0.029 |
hERG Blockers: | 0.003 | Human Hepatotoxicity (H-HT): | 0.375 |
Drug-inuced Liver Injury (DILI): | 0.698 | AMES Toxicity: | 0.534 |
Rat Oral Acute Toxicity: | 0.031 | Maximum Recommended Daily Dose: | 0.324 |
Skin Sensitization: | 0.694 | Carcinogencity: | 0.567 |
Eye Corrosion: | 0.003 | Eye Irritation: | 0.01 |
Respiratory Toxicity: | 0.132 |
Similar NPs | Similar Drugs | ||||||
---|---|---|---|---|---|---|---|
NPs ID | NPs 2D Structure | Similarity Score | TTD ID | Drug 2D Structure | Similarity Score | ||
ENC005339 | 0.827 | D03VFL | 0.295 | ||||
ENC005337 | 0.767 | D0WY9N | 0.269 | ||||
ENC005340 | 0.726 | D0G4OD | 0.250 | ||||
ENC003495 | 0.697 | D0FX2Q | 0.246 | ||||
ENC003114 | 0.645 | D04VEJ | 0.223 | ||||
ENC003496 | 0.636 | D0G3DL | 0.223 | ||||
ENC003842 | 0.636 | D0Q0PR | 0.219 | ||||
ENC005341 | 0.630 | D0R6RC | 0.218 | ||||
ENC003494 | 0.617 | D02GAC | 0.218 | ||||
ENC004068 | 0.329 | D05CHI | 0.217 |